VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company, has reported encouraging data from a retrospective analysis evaluating the cardiovascular safety of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE